Vancouver, B.C., March 31, 2021 – Pure Extracts Technologies Corp. (CSE:PULL)(OTC:PRXTF) (“Pure Extracts”) and Psyence Group Inc. (CSE: PSYG) (“Psyence”), are pleased to announce the signing of a Letter of Intent (“LOI”) to form a Joint Venture (the “JV”) to develop superior techniques for the extraction of psilocybin from psychedelic mushrooms, as well as the development of advanced formulations containing psilocybin for the long-term treatment of psychological trauma and its mental health consequences.
Psyence is one of the world’s first psychedelic mushroom companies operating a federally legal commercial cultivation and extraction facility in Southern Africa and ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer .
For further details see:
Pure Extracts And Psyence Group Sign JV Letter Of Intent For The Extraction of Psilocybin From Psychedelic Mushrooms And Development Of Psilocybin Formulations